Cargando…
Beginning at the ends: telomeres and human disease
Studies of rare and common illnesses have led to remarkable progress in the understanding of the role of telomeres (nucleoprotein complexes at chromosome ends essential for chromosomal integrity) in human disease. Telomere biology disorders encompass a growing spectrum of conditions caused by rare p...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931273/ https://www.ncbi.nlm.nih.gov/pubmed/29770205 http://dx.doi.org/10.12688/f1000research.14068.1 |
_version_ | 1783319619491069952 |
---|---|
author | Savage, Sharon A. |
author_facet | Savage, Sharon A. |
author_sort | Savage, Sharon A. |
collection | PubMed |
description | Studies of rare and common illnesses have led to remarkable progress in the understanding of the role of telomeres (nucleoprotein complexes at chromosome ends essential for chromosomal integrity) in human disease. Telomere biology disorders encompass a growing spectrum of conditions caused by rare pathogenic germline variants in genes encoding essential aspects of telomere function. Dyskeratosis congenita, a disorder at the severe end of this spectrum, typically presents in childhood with the classic triad of abnormal skin pigmentation, nail dystrophy, and oral leukoplakia, accompanied by a very high risk of bone marrow failure, cancer, pulmonary fibrosis, and other medical problems. In contrast, the less severe end of the telomere biology disorder spectrum consists of middle-age or older adults with just one feature typically seen in dyskeratosis congenita, such as pulmonary fibrosis or bone marrow failure. In the common disease realm, large-scale molecular epidemiology studies have discovered novel associations between illnesses, such as cancer, heart disease, and mental health, and both telomere length and common genetic variants in telomere biology genes. This review highlights recent findings of telomere biology in human disease from both the rare and common disease perspectives. Multi-disciplinary collaborations between clinicians, basic scientists, and epidemiologist are essential as we seek to incorporate new telomere biology discoveries to improve health outcomes. |
format | Online Article Text |
id | pubmed-5931273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-59312732018-05-15 Beginning at the ends: telomeres and human disease Savage, Sharon A. F1000Res Review Studies of rare and common illnesses have led to remarkable progress in the understanding of the role of telomeres (nucleoprotein complexes at chromosome ends essential for chromosomal integrity) in human disease. Telomere biology disorders encompass a growing spectrum of conditions caused by rare pathogenic germline variants in genes encoding essential aspects of telomere function. Dyskeratosis congenita, a disorder at the severe end of this spectrum, typically presents in childhood with the classic triad of abnormal skin pigmentation, nail dystrophy, and oral leukoplakia, accompanied by a very high risk of bone marrow failure, cancer, pulmonary fibrosis, and other medical problems. In contrast, the less severe end of the telomere biology disorder spectrum consists of middle-age or older adults with just one feature typically seen in dyskeratosis congenita, such as pulmonary fibrosis or bone marrow failure. In the common disease realm, large-scale molecular epidemiology studies have discovered novel associations between illnesses, such as cancer, heart disease, and mental health, and both telomere length and common genetic variants in telomere biology genes. This review highlights recent findings of telomere biology in human disease from both the rare and common disease perspectives. Multi-disciplinary collaborations between clinicians, basic scientists, and epidemiologist are essential as we seek to incorporate new telomere biology discoveries to improve health outcomes. F1000 Research Limited 2018-05-01 /pmc/articles/PMC5931273/ /pubmed/29770205 http://dx.doi.org/10.12688/f1000research.14068.1 Text en Copyright: © 2018 Savage SA http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) is/are employees of the US Government and therefore domestic copyright protection in USA does not apply to this work. The work may be protected under the copyright laws of other jurisdictions when used in those jurisdictions. |
spellingShingle | Review Savage, Sharon A. Beginning at the ends: telomeres and human disease |
title | Beginning at the ends: telomeres and human disease |
title_full | Beginning at the ends: telomeres and human disease |
title_fullStr | Beginning at the ends: telomeres and human disease |
title_full_unstemmed | Beginning at the ends: telomeres and human disease |
title_short | Beginning at the ends: telomeres and human disease |
title_sort | beginning at the ends: telomeres and human disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931273/ https://www.ncbi.nlm.nih.gov/pubmed/29770205 http://dx.doi.org/10.12688/f1000research.14068.1 |
work_keys_str_mv | AT savagesharona beginningattheendstelomeresandhumandisease |